Jim Fink Investing

Publications

AMGN, CI: Charging Bull Rolls

Jim Fink / Rolls

Please Note: Two Separate Rolls   Please Note: The following recommended opening trade only applies to those VT members who already have positions in the Amgen February (1st week) call credit spread. Do NOT do this trade as an initial position. 1. Vertical Roll on Amgen (Nasdaq: AMGN) to Iron Condor in April “Buy to […]… Read More


ADI: Locking in Profits

Jim Fink, Derek Myers / Rolls

  Closeout Double Diagonal on Analog Devices (Nasdaq: ADI) “Buy to Close” February (1st week) $185 Put and “Sell to Close” March (3rd week) $175 Put and “Buy to Close” February (1st week) $210 Call and “Sell to Close” March (3rd week) $220 Call Option Symbols: ADI240202P185 and ADI240315P175 and ADI240202C210 and ADI240315C220 Limit Order […]… Read More


META: Earnings Surprise Roll

Jim Fink / Rolls

1(a). Closeout on Meta Platforms (Nasdaq: META) as Part of Vertical Roll “Buy to Close” February $365 Put and “Sell to Close” February $325 Put and “Buy to Close” February $420 Call and “Sell to Close” February $460 Call Option Symbols: META240216P325 and META240216P365 and META240216C420 and META240216C460 Limit Order Price: Net debit of $34.95 […]… Read More


INTU: Verified and Closed

Jim Fink, Derek Myers / Options Trades

Double Diagonal on Intuit (Nasdaq: INTU) CLOSED The reported fills of $6.80 or higher have been verified, so we are closing the trade. If your trade did not close, you have two choices, close or manage the trade independently; the option is yours. The current mid-price to close is a net credit of $7.05. If […]… Read More


MEDP, NTES: Wholly Hedges

Jim Fink / New Trades

Please Note: Two Separate Trades Valid Through Monday February 12th   1. Call Credit Spread on Medpace Holdings (Nasdaq: MEDP) “Buy to Open” March $310 Call and “Sell to Open” March $300 Call Option Symbols: MEDP240315C300 and MEDP240315C310 Limit Order Price: Net credit of $3.50 or more ($350 per spread) – good ’til canceled (GTC) […]… Read More


CI, CRWD: Healthcare and Security

Jim Fink / New Trades

  Please Note: Two Separate Trades   1. Put Credit Spread on CrowdStrike Holdings (Nasdaq: CRWD) “Buy to Open” February (2nd week) $297.50 Put and “Sell to Open” February (2nd week) $300 Put Option Symbols: CRWD240209P297.5 and CRWD240209P300 Limit Order Price: Net credit of $1.25 or more ($125 per spread) — good ’til canceled (GTC) […]… Read More


NKE, SMH: Running Circuits

Jim Fink, Derek Myers / New Trades

Please Note: Two New Trades Valid Through Monday, February 5th   1. Double Diagonal on Nike (NYSE: NKE) “Buy to Open” April $92.50 Put and “Sell to Open” March $97.50 Put and “Buy to Open” April $115 Call and “Sell to Open” March $110 Call Option Symbols: NKE240419P92.5 and NKE240315P97.5 and NKE240419C115 and NKE240315C110 Limit […]… Read More


CAH, AAPL: Roll & Close

Jim Fink, Derek Myers / Rolls

Please Note: One Roll & One Closeout   Please Note: The following recommended opening trade only applies to those Inner Circle members who already have a position in the Cardinal Health January (4th week) iron condor. Do NOT enter this trade as an initial position. 1. Vertical Roll to Iron Condor on Cardinal Health (NYSE: […]… Read More


PANW: Condor Correction

Jim Fink / Rolls

1(a). Closeout on Palo Alto Networks (Nasdaq: PANW) as Part of Vertical Roll “Buy to Close” February (3rd week) $210 Put and “Sell to Close” February (3rd week) $190 Put and “Buy to Close” February (3rd week) $290 Call and “Sell to Close” February (3rd week) $310 Call Option Symbols: PANW240216P190 and PANW240216P210 and PANW240216C290 […]… Read More


META, Z: Overshoot Amendment

Jim Fink / Rolls

Please Note: Two Separate Rolls   1(a). Closeout on Meta Platforms (Nasdaq: META) as Part of Vertical Roll “Buy to Close” February $300 Put and “Sell to Close” February $260 Put and “Buy to Close” February $360 Call and “Sell to Close” February $400 Call Option Symbols: META240216P260 and META240216P300 and META240216C360 and META240216C400 Limit […]… Read More


1 107 108 109 110 111 439

Search Jim Fink Investing